Logistics outsourcing company D. Logistics of Germany announced an agreement with Siemens Medical Engineering Group to start a new e-business venture in Europe’s medical market. Siemens will hold a 51% stake in the new company.The new company will
Logistics outsourcing company D. Logistics of Germany announced an agreement with Siemens Medical Engineering Group to start a new e-business venture in Europes medical market. Siemens will hold a 51% stake in the new company.
The new company will be aimed at establishing an electronic business communications platform for e-business between suppliers and customers in medical markets.
Using the new platform, hospitals, private medical practices, and pharmacies will be able to communicate via network channels with suppliers of their choice to speed orders for materials and medicines.
Siemens as a whole expects to soon be generating more than 25% of its total sales with e-business activity.
In addition to outsourcing optimizing logistics, D. Logistics sells B2B customers consulting services, temporary help, and tailored information technology. The company has 1200 employees and is headquartered in Leverkusen, Germany.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.